Back

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Cardiac ITU Is about the Heart, and More Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Junichi Ishii

Fujita Health University Second Hospital, Nagoya (Japan)

6 More presentations in this session

Presentation thumbnail
Mechanical ventilation in cardiac arrest: association between hyperoxia, hypercarbia and positive end-expiratory pressure with mortality
Assistant Professor C. Alviar (New York, US)
Abstract Slides
Presentation thumbnail
Hyperoxia is Associated with Adverse Outcomes in the Cardiac Intensive Care Unit: Insights from the Medical Information Mart for Intensive Care (MIMI-III) Database
Mr A. Lui (New York, US)
Abstract Slides
Presentation thumbnail
Agitation and delirium in intensive cardiac care unit. A multicenter prospective registry
Doctor M. Moltrasio (Milan, IT)
Abstract Slides
Presentation thumbnail
The prognostic impact of right ventricular dysfunction in patients with septic cardiomyopathy
Doctor H. Hiraiwa (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Residual inflammation is a major determinant of myocardial recovery and cardiovascular outcome in takotsubo patients
Doctor L. Lachmet-Thebaud (Strasbourg, FR)
Abstract Slides

Access the full session

Session thumbnail
Cardiac ITU Is about the Heart, and More

The Event

Event poster

ESC Congress 2020

1 September 2020 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources